Personal tools
Home

Welcome to the UCLA Department of Bioengineering!


The UCLA Bioengineering B.S. Degree is ABET Accredited

bigger ABET 2

The Bachelor of Science program in the Department of Bioengineering has successfully completed its first ever ABET accreditation review!  The ABET accreditation has been conferred beginning with our most recent June 2013 graduates.  For more information on ABET accreditation, please visit http://abet.org/vision-mission/

null

BE Faculty Dr. Di Carlo Awarded 2014 Analytical Chemistry Young Innovator Award

 

Dr. Dino Di Carlo received the 2014 Analytical Chemistry Young Innovator Award at the MicroTAS conference on October 28. 

10447627_10103853585690206_2630112962312520010_nsmall.jpg

This award, sponsored by the Analytical Chemistry journal and the Chemical and Biological Microsystems Division (CBMS), recognizes the contributions of an individual who has demonstrated exceptional technical advancement and innovation in the field of micro- or nanofluidics in his or her early career.

Learn more about the Young Innovator award here.

More information on MicroTAS can be found here.

 

null

 

BE Faculty Dr. Kasko and Dr. Wong engineer persister-specific antibiotics

 
persister

Most antibiotics target growth processes and are ineffective against persister bacterial cells, which tolerate antibiotics due to their reduced metabolic activity. These persisters act as a genetic reservoir for resistant mutants and constitute a root cause of antibiotic resistance, a worldwide problem in human health. We re-engineer antibiotics specifically for persisters using tobramycin, an aminoglycoside antibiotic that targets bacterial ribosomes but is ineffective against persisters with low metabolic and cellular transport activity. By giving tobramycin the ability to induce nanoscopic negative Gaussian membrane curvature via addition of 12 amino acids, we transform tobramycin itself into a transporter sequence. The resulting molecule spontaneously permeates membranes, retains the high antibiotic activity of aminoglycosides, kills E. coli and S. aureus persisters 4–6 logs better than tobramycin, but remains noncytotoxic to eukaryotes. These results suggest a promising paradigm to renovate traditional antibiotics.

 

null

BE Undergraduate Shannon Wongvibulsin awarded 2013-2014 HSSEAS Schoolwide Outstanding Bachelor of Science Award

 

null

Bioengineering senior Shannon Wongvibulsin has been awarded the 2013-2014 HSSEAS Schoolwide Outstanding Bachelor of Science Award.  School-wide awards were selected by a committee comprised of students, faculty, and staff.  The award will be acknowledged in the 2014 HSSEAS Commencement program and at the ceremony.  The Department of Bioengineering has only had 8 years of graduates, and Shannon is the 7th student from the Department to be selected for this honor.  The other students selected for this honor were Jaideep Dudani (2012-2013), Armin Arshi (2011-2012), Shivani Dharmaraja (2010-2011), Byron Kwan (2009-2010), Nicholas Kusnezov (2008-2009), and James Pinney (2006-2007).        Read more...

null

Bioengineering Grad Kristine Mayle named C200 Scholar

 
"Kristine Mayle, a Ph.D. student in bioengineering at the UCLA Henry Samueli School of Engineering and Applied Science, recently was named a Larraine Segil C200 Scholar. The honor, from the Committee of 200 recognizes outstanding women studying in a field of science, technology, engineering, or mathematics (STEM) with leadership potential, entrepreneurial spirit and a commitment to supporting women.  A member of Professor Daniel T. Kamei’s laboratory, Mayle enrolled at UCLA after graduating from Ohio University with bachelor’s degree in chemical engineering.  She is also a recipient of the National Science Foundation’s Graduate Research Fellowship. Mayle answered a few questions on her studies and plans here."
 

null

Bioengineering Faculty Chih-Ming Ho elected a distinguished Fellow of the AIMBE

 

null

UCLA MAE Professor Chih-Ming Ho has been elected a distinguished Fellow of the American Institute for Medical and Biological Engineering (AIMBE) for his seminal impacts made in the microfluidic system technology for applications in medical diagnosis and biological research. The induction of the Class of 2014 took place on March 24, 2014, at the National Academy of Sciences (NAS).

AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. It is an organization of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected Fellows.

null

Breakthrough therapy allows four paraplegic men to voluntarily move their legs

 

null


Four young men who have been paralyzed for years achieved groundbreaking progress — moving their legs — as a result of epidural electrical stimulation of the spinal cord, which was helped to be developed by Bioengineering affiliate faculty Dr. Edgerton.

Read more...

 

null

Bioengineering faculty's smartphone attachment detects ionic mercury

mercury

A new smartphone attachment from Aydogan Ozcan and his colleagues allows researchers to measure mercury ion concentrations in water samples by snapping a picture.  A water sample is added to a salt solution containing gold nanoparticles and aptamers.  If the water contains mercury, the nanoparticles go from emitting red to blue light, which can be captured by the smartphone.

 
 
null
 
 

UCLA Bioengineering top 10 in National Research Council Rankings 

 

UCLA Bioengineering ranked in the top 10 of all bioengineering doctorate programs across the country based on a recent evaluation by the independent National Research Council (NRC). Both survey-based and regression-based rankings placed UCLA BE in top 10. More details on the rankings can be found at http://www.nap.edu/rdp/

 null

Document Actions
Calendar
October
« October 2014 »
MoTuWeThFrSaSu
12345
6789101112
13141516171819
20212223242526
2728293031